home All News open_in_new Full Article

Appili Therapeutics Announces Submission of U.S. Federal Government Funding Proposals and Provides Corporate and Aditxt Transaction Update

Four new funding proposals, totalling US$117.5 million, have been submitted for reviewModifications received to U.S. Air Force Academy Cooperative AgreementOutside date for going-private transaction extended to March 31, 2025 HALIFAX, Nova Scotia, March 18, 2025 (GLOBE NEWSWIRE) — Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug […]



Appili Therapeutics submitted four U.S. federal funding proposals totaling US$117.5 million for infectious disease treatment development. Modifications were received for the U.S. Air Force Academy Cooperative Agreement. The deadline for the Aditxt going-private transaction was extended to March 31, 2025.

today 24 h. ago attach_file Politics

attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Economics
attach_file Politics
attach_file Economics
attach_file Economics
attach_file Other
attach_file Other
attach_file Society
attach_file Economics
attach_file Events
attach_file Economics
attach_file Economics
attach_file Economics
attach_file Other
attach_file Economics
attach_file Economics
attach_file Economics


ID: 1667837019
Add Watch Country

arrow_drop_down